Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008124

Director sold 13,471 shares at $9.86 ($132,851)

From the SEC's structured data for this filing

Trades in this filing

Kauffman Michael · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-07 Sale : show line 1 in the form −6,764 $9.86 $66,707 708,062 D
2022-02-07 Sale : show line 2 in the form −6,707 $9.86 $66,144 913,445 I
Open-market sales · 13,471 sh · avg $9.86 · $132,851
Loading xslF345X03/doc4.xml…